PUBLISHER: The Business Research Company | PRODUCT CODE: 1760463
PUBLISHER: The Business Research Company | PRODUCT CODE: 1760463
An appetite stimulant refers to any substance or product designed to increase an individual's appetite, particularly in cases where hunger is lost due to medical conditions, treatments, or other factors. These stimulants work by influencing hormones or brain functions that control hunger signals, thereby promoting the desire to eat.
The main types of appetite stimulants are prescription, over-the-counter, and natural. Prescription appetite stimulants are medications used under medical supervision to help boost hunger in individuals experiencing significant appetite loss due to conditions such as cancer, HIV/AIDS, or chronic illnesses. These stimulants are available in various forms, including liquid formulations, powder formulations, capsules and tablets, and functional foods. They are distributed through different channels, such as hospital pharmacies, online pharmacies, and retail pharmacies, and are used by a wide range of end-users, including hospitals, homecare providers, and specialty centers.
The appetite stimulant market research report is one of a series of new reports from The Business Research Company that provides appetite stimulant market statistics, including the appetite stimulant industry global market size, regional shares, competitors with the appetite stimulant market share, detailed appetite stimulant market segments, market trends, and opportunities, and any further data you may need to thrive in the appetite stimulant industry. This appetite stimulant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The appetite stimulant market size has grown strongly in recent years. It will grow from $1.75 billion in 2024 to $1.92 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth during the historic period can be attributed to the increased prevalence of cancer and HIV-related cachexia, off-label use of antidepressants for weight gain, a rise in awareness of malnutrition, hospital-based nutrition management, and the use of corticosteroids in chronic illness care.
The appetite stimulant market size is expected to see strong growth in the next few years. It will grow to $2.69 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to the rising burden of chronic diseases, a growing aging population, the expanding use of appetite stimulants in pediatrics, increasing demand for nutritional supplements, and regulatory approvals of new drugs. Major trends expected during this period include technological advancements in drug formulation, innovations in protein-based supplements, the development of cannabinoid-based therapies, personalized nutrition and precision medicine, and ongoing research and development in ghrelin receptor agonists.
The rising prevalence of chronic diseases is expected to fuel the growth of the appetite stimulant market in the coming years. Chronic diseases are long-term medical conditions that typically last for three months or more and often worsen over time. The increasing prevalence of chronic diseases is primarily linked to poor dietary habits, including high consumption of processed foods, sugars, and unhealthy fats, which contribute to obesity, diabetes, cardiovascular diseases, and other conditions. Appetite stimulants play a critical role in managing chronic diseases by improving overall nutritional status and enhancing hunger, which can help patients gain or maintain weight. For example, the Australian Institute of Health and Welfare reported in June 2024 that the rate of deaths attributed to chronic conditions increased from 459 per 100,000 population in 2021 to 490 per 100,000 in 2022. As the demand for nutritional support rises due to these health conditions, the appetite stimulant market continues to expand.
Companies in the appetite stimulant market are increasingly focusing on innovative products, including Ayurvedic appetite stimulants, to attract health-conscious consumers. Ayurvedic appetite stimulants are natural remedies derived from traditional herbs that help enhance digestion, stimulate digestive fire, and improve nutrient absorption, all of which can increase appetite. For example, in October 2024, Lupin Limited, an India-based pharmaceutical company, launched the Aptivate Achi Bhookh Fest, a campaign aimed at promoting healthy eating habits and nutrition awareness among children. The event includes interactive activities and expert-led sessions, with plans to reach 250,000 people across schools and residential areas. The campaign features Aptivate, an Ayurvedic appetite stimulant for children, designed to encourage healthy eating habits and promote strong immunity, highlighting the growing interest in natural and holistic approaches to nutrition.
In January 2025, Zuellig Pharma Corporation, a Singapore-based healthcare distribution and pharmaceutical solutions company, acquired the Propan brand from ADP Pharma Corporation for an undisclosed amount. With this acquisition, Zuellig Pharma aims to enhance its consumer health portfolio by adding a trusted appetite stimulant and multivitamin brand, strengthening its ability to offer high-quality healthcare solutions tailored to the nutritional needs of various age groups. ADP Pharma Corporation, based in the Philippines, specializes in appetite stimulants, and this acquisition enables Zuellig Pharma to expand its presence in the growing appetite stimulant market.
Major players in the appetite stimulant market are Bristol Myers Squibb, Novartis AG, Solvay Pharmaceuticals, Lupin Limited, TIL Healthcare Private Limited, Zeon Lifesciences Limited, Apex Laboratories Private Limited, Nuray Chemicals Private Limited, Arlak Biotech Private Limited, AdvaCare Pharma USA LLC, Dwarkesh Pharmaceuticals Private Limited, Par Pharmaceutical Companies, Inc., Salvus Healthcare Private Limited, Epitome Pharmaceuticals Private Limited, Abiba Pharmacia Private Limited, Pharmika India Private Limited, Wellona Pharma, SiNi Pharma, Vibcare Pharma Private Limited, Mayons Pharmaceuticals Private Limited.
North America was the largest region in the appetite stimulant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in appetite stimulant report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the appetite stimulant market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The appetite stimulant market consists of sales of cyproheptadine, mirtazapine, and anamorelin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified.)
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Appetite Stimulant Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on appetite stimulant market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for appetite stimulant ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The appetite stimulant market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.